| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |